Literature DB >> 16584134

Role of bioactivation in drug-induced hypersensitivity reactions.

Joseph P Sanderson1, Dean J Naisbitt, B Kevin Park.   

Abstract

Drug-induced hypersensitivity reactions are a major problem in both clinical treatment and drug development. This review covers recent developments in our understanding of the pathogenic mechanisms involved, with special focus on the potential role of metabolism and bioactivation in generating a chemical signal for activation of the immune system. The possible role of haptenation and neoantigen formation is discussed, alongside recent findings that challenge this paradigm. Additionally, the essential role of costimulation is examined, as are the potential points whereby costimulation may be driven by reactive metabolites. The relevance of local generation of metabolites in determining the location and character of a reaction is also covered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584134      PMCID: PMC2751424          DOI: 10.1208/aapsj080107

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  134 in total

1.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Authors:  Seung-Yong Seong; Polly Matzinger
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

2.  Drug presentation to T cells.

Authors:  Dean John Naisbitt; Munir Pirmohamed; Brian Kevin Park
Journal:  J Allergy Clin Immunol       Date:  2005-04       Impact factor: 10.793

3.  Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers.

Authors:  A K Mitra; K E Thummel; T F Kalhorn; E D Kharasch; J D Unadkat; J T Slattery
Journal:  Clin Pharmacol Ther       Date:  1996-03       Impact factor: 6.875

4.  Regulation by allergens of chemokine receptor expression on in vitro-generated dendritic cells.

Authors:  Fabrice Jugdé; Christine Boissier; Nathalie Rougier-Larzat; Anne Corlu; Christophe Chesné; Gilbert Semana; Denis Heresbach
Journal:  Toxicology       Date:  2005-09-01       Impact factor: 4.221

5.  Sulfamethoxazole is metabolized to the hydroxylamine in humans.

Authors:  A E Cribb; S P Spielberg
Journal:  Clin Pharmacol Ther       Date:  1992-05       Impact factor: 6.875

6.  Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.

Authors:  Sanjoy Roychowdhury; Piyush M Vyas; Timothy P Reilly; Anthony A Gaspari; Craig K Svensson
Journal:  J Pharmacol Exp Ther       Date:  2005-03-22       Impact factor: 4.030

7.  Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.

Authors:  A E Cribb; M Miller; A Tesoro; S P Spielberg
Journal:  Mol Pharmacol       Date:  1990-11       Impact factor: 4.436

Review 8.  The role of metabolic activation in drug-induced hepatotoxicity.

Authors:  B Kevin Park; Neil R Kitteringham; James L Maggs; Munir Pirmohamed; Dominic P Williams
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

9.  Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS.

Authors:  Muriel Eliaszewicz; Antoine Flahault; Jean-Claude Roujeau; Anne Marie Fillet; Dominique Challine; Samira Mansouri; Pierre Wolkenstein; Sélim Aractingi; Dominique Penso-Assathiany; Caroline Maslo; Isabelle Bourgault-Villada; Olivier Chosidow; Eric Caumes
Journal:  J Am Acad Dermatol       Date:  2002-07       Impact factor: 11.527

Review 10.  T cell immune responses to haptens. Structural models for allergic and autoimmune reactions.

Authors:  H U Weltzien; C Moulon; S Martin; E Padovan; U Hartmann; J Kohler
Journal:  Toxicology       Date:  1996-02-22       Impact factor: 4.221

View more
  7 in total

1.  Covalent protein binding and tissue distribution of houttuynin in rats after intravenous administration of sodium houttuyfonate.

Authors:  Zhi-peng Deng; Da-fang Zhong; Jian Meng; Xiao-yan Chen
Journal:  Acta Pharmacol Sin       Date:  2012-03-05       Impact factor: 6.150

2.  The use of immobilized cytochrome P4502C9 in PMMA-based plug flow bioreactors for the production of drug metabolites.

Authors:  Lance A Wollenberg; Jarod L Kabulski; Matthew J Powell; Jifeng Chen; Darcy R Flora; Timothy S Tracy; Peter M Gannett
Journal:  Appl Biochem Biotechnol       Date:  2013-10-30       Impact factor: 2.926

Review 3.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

4.  Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients.

Authors:  Danxin Wang; Amanda Curtis; Audrey C Papp; Susan L Koletar; Michael F Para
Journal:  BMC Med Genomics       Date:  2012-07-23       Impact factor: 3.063

5.  Role of mesotherapy in musculoskeletal pain: opinions from the italian society of mesotherapy.

Authors:  Massimo Mammucari; Antonio Gatti; Sergio Maggiori; Alessandro F Sabato
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-13       Impact factor: 2.629

Review 6.  Bioactive Graphene Quantum Dots Based Polymer Composite for Biomedical Applications.

Authors:  Seyyed Mojtaba Mousavi; Seyyed Alireza Hashemi; Masoomeh Yari Kalashgrani; Navid Omidifar; Sonia Bahrani; Neralla Vijayakameswara Rao; Aziz Babapoor; Ahmad Gholami; Wei-Hung Chiang
Journal:  Polymers (Basel)       Date:  2022-02-05       Impact factor: 4.329

7.  Detoxifying Enzymes at the Cross-Roads of Inflammation, Oxidative Stress, and Drug Hypersensitivity: Role of Glutathione Transferase P1-1 and Aldose Reductase.

Authors:  Francisco J Sánchez-Gómez; Beatriz Díez-Dacal; Elena García-Martín; José A G Agúndez; María A Pajares; Dolores Pérez-Sala
Journal:  Front Pharmacol       Date:  2016-08-04       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.